Sclerosis: all 3,103 studies
Page 24 of 32. Open to participants first (314), then studies with results posted, then the rest; newest registration first within each.
- Study of Electrical Impedance Myography (EIM) in ALSCompletedNCT02011204
- Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MSCompletedNCT02010554Not applicable
- Effects of the Cross-Training in Patients With Multiple SclerosisCompletedNCT02010398Not applicable
- Evaluation of Nutritional Status and Fatigue in Patients With Multiple SclerosisCompletedNCT02008669
- Exercise in Multiple Sclerosis: Effects on Cognitive Function and Brain ConnectivityCompletedNCT02005237Not applicable
- JC Virus Reactivation in Multiple SclerosisCompletedNCT02004444
- Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)TerminatedNCT02000713Not applicable
- A Safety Study of sNN0029 Administration Via Intracerebroventricular Route to Patients With ALSTerminatedNCT01999803Phase 1
- Correlation Between Relapses in Multiple Sclerosis (MS) and Vitamin D IntakeCompletedNCT01994018
- FlexToBa for People With Multiple SclerosisCompletedNCT01993095Not applicable
- Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting CellsCompletedNCT01993004
- Body Weight Supported Treadmill Training in Persons With Multiple SclerosisCompletedNCT01992679Phase 1/2
- Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral SclerosisTerminatedNCT01992029
- Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in RelapseCompletedNCT01986998Phase 4
- Stem Cell Therapy for Amyotrophic Lateral SclerosisWithdrawnNCT01984814Phase 2
- Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple SclerosisCompletedNCT01981161
- Intellectual Enrichment to Build Cognitive Reserve in MSCompletedNCT01978574Not applicable
- Walking With FES or AFO in People With MS With Foot DropCompletedNCT01977287
- A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)WithdrawnNCT01975298Phase 3
- High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating DiseasesWithdrawnNCT01973517
- Lower Urinary Tract Symptoms in Systemic SclerosisCompletedNCT01971294
- Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis PatientsCompletedNCT01968902Phase 4
- Dysfunctions and Plasticity Mechanisms of Motor System Assessed by Cortico-cortical and Cortico-muscular Coherence Analysis in Amyotrophic Lateral SclerosisSuspendedNCT01959373Not applicable
- Fall Risk Reduction in Multiple Sclerosis: Exercise Versus BehaviorCompletedNCT01956227Phase 1/2
- Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative DiseasesWithdrawnNCT01954875
- Use of an Electronic Diary by People With Multiple SclerosisStatus unknownNCT01954823Not applicable
- A Study of Everolimus in the Treatment of Neurocognitive Problems in Tuberous SclerosisStatus unknownNCT01954693Phase 2
- Effect of Vitamin D Replacement on Immune Function and Cognition in MS PatientsCompletedNCT01952483
- Establishment of a Tissue Bank (Blood, CSF) for the Understanding of Motor Neuron Disease (MND)TerminatedNCT01950910
- Identification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose SamplesCompletedNCT01948102
- Magnetic Resonance Imaging (MRI) in Amyotrophic Lateral Sclerosis (ALS)WithdrawnNCT01945853Not applicable
- Pilot Study to Assess Disease Stability in a Natalizumab to Dimethyl Fumarate Crossover DesignCompletedNCT01945359
- Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic SclerosisStatus unknownNCT01943968Not applicable
- Safety and Efficacy of Fingolimod in MS Patients in ChinaWithdrawnNCT01941004Phase 3
- Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01938495Phase 2
- A Clinical Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS)Status unknownNCT01935518Phase 2
- Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Patients With Multiple SclerosisCompletedNCT01933802Phase 1
- Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01933321Phase 2/3
- Repeat Infusion of Autologous Bone Marrow Cells in Multiple SclerosisCompletedNCT01932593Not applicable
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported OutcomesCompletedNCT01930708Phase 4
- Development of a Motivational Intervention to Improve Treatment Adherence in MSCompletedNCT01925690Not applicable
- Effect of I-TRAVLE Training on Arm Function in MS and Chronic Stroke PatientsStatus unknownNCT01918748Not applicable
- Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis PatientsStatus unknownNCT01918501Not applicable
- A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple SclerosisCompletedNCT01917019Phase 3
- Wahls Paleo Diet and Progressive Multiple SclerosisCompletedNCT01915433Not applicable
- Functional Electrical Stimulation for People With Multiple Sclerosis Who Experience Foot DropCompletedNCT01914016Not applicable
- Biogen Multiple Sclerosis Pregnancy Exposure RegistryCompletedNCT01911767
- MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation TrialCompletedNCT01910259Phase 2
- Comprehensive Analysis of Relapse in Multiple SclerosisStatus unknownNCT01906684Not applicable
- Adherence Trial With MS LifeLines ® ServicesTerminatedNCT01905527
- Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMSCompletedNCT01903291
- Evaluation of the Response to Acthar Gel Therapy in Patients Who Failed Intravenous Methylprednisolone (IVMP) for MS RelapsesStatus unknownNCT01900093Not applicable
- Communication by Brain - Computer Interface in Amyotrophic Lateral Sclerosis:Feasibility StudyStatus unknownNCT01897818Not applicable
- Safety and Efficacy Study of Autologus Bone Marrow Mesenchymal Stem Cells in Multiple SclerosisCompletedNCT01895439Phase 1/2
- Lung Volume Recruitment for Lung Function and Cough Impairment in Multiple SclerosisStatus unknownNCT01891071Not applicable
- Extension Study of MT-1303CompletedNCT01890655Phase 2
- Monitoring of Non-invasive Ventilation During Sleep in ALSCompletedNCT01889043
- Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous (SQ)Versus ACTHar Gel Five Days SQ for the Treatment of MS ExacerbationsCompletedNCT01888354Phase 4
- PK and PD Study of Natalizumab in Pediatric Subjects With RRMSCompletedNCT01884935Phase 1
- Safety and Efficacy of BMMNC in Multiple Sclerosis (MS)Status unknownNCT01883661Phase 1/2
- Task-oriented Circuit Training Combined With Cerebellar tDCS in Multiple Sclerosis SubjectsCompletedNCT01883310Not applicable
- Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 MonthsCompletedNCT01881191
- Study of Rasagiline in Patients With Amyotrophic Lateral SclerosisCompletedNCT01879241Phase 2
- Methylphenidate as Treatment Option of Fatigue in Multiple SclerosisStatus unknownNCT01879202Phase 2
- A Trial to Compare the Effectiveness of Two Rehabilitation Programs for Multiple Sclerosis PatientsCompletedNCT01871818Not applicable
- Exercises for Urinary Incontinence(UI) of Women With Multiple Sclerosis (MS)CompletedNCT01871337Not applicable
- Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis.WithdrawnNCT01868048Phase 3
- Prospective Longitudinal 1-year Study of the Correlation Between Cognitive Functioning in Patients With Clinically Isolated Syndrome Suggestive of Multiple Sclerosis and Disconnection in the Brain Assessed by MRICompletedNCT01865357Not applicable
- Interventional Clinical Trial for CCSVI in Multiple Sclerosis PatientsCompletedNCT01864941Phase 1/2
- Acupuncture or MBSR for Patients With Fatigue and MSCompletedNCT01864707Not applicable
- Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple SclerosisCompletedNCT01863888Phase 3
- Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic SclerosisStatus unknownNCT01858259
- MEsenchymal StEm Cells for Multiple SclerosisStatus unknownNCT01854957Phase 1/2
- Natural History of Optic NeuritisTerminatedNCT01851434
- Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple SclerosisCompletedNCT01848327Not applicable
- A Longitudinal Study of Brain Atrophy in MS Patients Over 5 YearsCompletedNCT01847287
- Sodium Intake in Multiple SclerosisCompletedNCT01846234
- Influence of High Intensity Exercise on Insulin Resistance, Muscle Contractile Properties, Aerobic Capacity and Body Composition in Multiple SclerosisCompletedNCT01845896Not applicable
- One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With SpasticityCompletedNCT01844232Phase 3
- Efficacy of Fish Oil in Multiple SclerosisCompletedNCT01842191Phase 4
- Development and Prevention of Pulmonary Hypertension in Systemic SclerosisStatus unknownNCT01840748
- Applying Speed of Processing Training to Individuals With Multiple SclerosisCompletedNCT01838824Not applicable
- An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT01838668Phase 3
- Project FARMS: Fall Risk Reduction in Multiple SclerosisCompletedNCT01837017Phase 1
- Prevention and Treatment of Digital Ulcers in Systemic SclerosisStatus unknownNCT01836263
- Imaging Multiple Sclerosis Lesions Using Magnevist and GadavistTerminatedNCT01836055
- Improvement of Hand Dysfunction by Arthritis in Systemic SclerosisStatus unknownNCT01834157
- Pilot Study of Free From Falls Program in Multiple SclerosisCompletedNCT01829776Not applicable
- Development and Prevention of Severe Heart Disease in Systemic SclerosisStatus unknownNCT01829126
- The Effect of GCSF in the Treatment of ALS PatientsCompletedNCT01825551Phase 2/3
- Home Exercise Intervention in Persons With Multiple SclerosisCompletedNCT01824550Not applicable
- Oral Health and People With Systemic SclerosisCompletedNCT01817361
- Efficacy of Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of MS After a Clinically Isolated SyndromeCompletedNCT01817166Phase 3
- The Effect of Exercise on Strength and Mobility and Corresponding CNS Plasticity in Multiple Sclerosis PatientsCompletedNCT01816100Not applicable
- Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS)Status unknownNCT01815632Phase 2
- Effects of Intensive Aerobic and Muscle Endurance Exercise in Patients With Systemic Sclerosis - a Pilot StudyCompletedNCT01813578Not applicable
- Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic SclerosisCompletedNCT01813279Not applicable
- A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple SclerosisStatus unknownNCT01811290
- A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS)TerminatedNCT01808482Phase 1